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The international conference “The Toxicology of Fumonisin” was held
28–30 June 1999 in Arlington, Virginia. The conference was spon-
sored by the U.S. Food and Drug Administration (FDA), the National
Institute of Environmental Health Sciences, the U.S. Department of
Agriculture, and the Technical Committee on Food Toxicology and
Safety Assessment, which is part of the International Life Sciences
Institute North America. The purpose of the conference was to assem-
ble, present, and critically review the available data on the chemistry,
toxicities, and mechanisms of action of the fumonisin mycotoxins; to
provide a forum for presentation of the National Toxicology Program
bioassay on fumonisin B1; to identify critical data gaps and research
needs; and to identify factors affecting the occurrence of fumonisin and
tools for fumonisin management and control.
The conference began with an address by W. Marasas, one of the
investigators who first identified the Fusarium mycotoxins and
linked exposure to these materials with high rates of human
esophageal cancers in South Africa. Marasas reviewed these studies
and explored the history of episodic poisonings worldwide, including
the outbreaks associated with the consumption of moldy corn by
livestock in the United States in 1989 and 1990. The chemistry of
the Fusarium mycotoxins, including their biosynthesis, was then
reviewed. Known toxicities of fumonisins and Fusarium toxins in
horses, pigs, rats, and nonhuman primates were covered, followed by
a session outlining the National Toxicology Program’s bioassay
results, which were positive for rat kidney and mouse liver.
Fumonisin B1 is a powerful inducer of apoptosis in certain organs
and this action has been linked to specific inhibition of ceramide
synthase, resulting in altered sphingolipid metabolism. This path-
way, as well as several other proposed mechanisms of carcinogenesis,
was then covered in depth. The conference concluded with a session
devoted to examining the conditions that favor mycotoxin growth in
corn and a number of strategies currently under development to pre-
vent further outbreaks. 
On 6 June 2000 the FDA released a draft guidance document,
“Guidance for Industry—Fumonisin Levels in Human Foods and
Animal Feeds” (1). The document stated that, on the basis of available
information on the adverse animal health effects associated with
fumonisins, human health risks associated with exposure to fumon-
isins are possible. The guidance document also stated that human
exposure to such natural toxins should not exceed certain levels achiev-
able with the use of good agricultural and good manufacturing prac-
tices. FDA’s guidance document notes that the maximum levels for
fumonisins in corn and corn products intended for human consump-
tion are based on concerns associated with hazards shown primarily by
animal studies, including the comprehensive toxicology studies con-
ducted at FDA’s National Center for Toxicological Research that were
supported by the National Institute of Environmental Health
Sciences/National Toxicology Program (2). 
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